Organon CEO resigns over 'improper' contraceptive sales Organon CEO Kevin Ali has stepped down after an audit found sales of the company's Nexplanon contraceptive implant in the US were inflated.

The chief executive of #Organon, Kevin Ali, has agreed to step down after an internal #investigation into #sales of its Nexplanon #contraceptiveimplant in the US revealed dubious practices.